Your browser doesn't support javascript.
loading
Adverse events reported after first dose of SARS-CoV-2 vaccine in the Northern Region of Ghana.
Dzantor, Edem Kojo; Asumah, Mubarick Nungbaso; Inusah, Abdul-Wahab; Nukpezah, Nimota Ruth; Agyeman, Yaa Nyarko; Kukeba, Margaret Wekem; Braimah, Baba Abubakari; Adjeso, Theophilus; Tahiru, Mohammed Mutaru.
Afiliação
  • Dzantor EK; Department of Epidemiology and Biostatistics, Fred N. Binka School of Public Health, University of Health and Allied Sciences, Hohoe, Ghana.
  • Asumah MN; Research and Innovation Unit, College of Nursing and Midwifery, Nalerigu- North-East Region, Ghana.
  • Inusah AW; Department of Global/International Health, School of Public Health, University for Development Studies, Tamale, Ghana.
  • Nukpezah NR; Kintampo Municipal Hospital, Ghana Health Service, Kintampo, Ghana.
  • Agyeman YN; Department of Global/International Health, School of Public Health, University for Development Studies, Tamale, Ghana.
  • Kukeba MW; Department of Preventive Nursing, School of Nursing and Midwifery, University for Development Studies, Tamale, Ghana.
  • Braimah BA; Department of Population and Reproductive Health, School of Public Health, University for Development Studies, Tamale, Ghana.
  • Adjeso T; Department of Nursing, School of Nursing and Midwifery, CKT-University of Technology and Applied Sciences, Navrongo, Ghana.
  • Tahiru MM; Department of Global/International Health, School of Public Health, University for Development Studies, Tamale, Ghana.
Nurs Open ; 10(3): 1785-1793, 2023 03.
Article em En | MEDLINE | ID: mdl-36326788
ABSTRACT

AIM:

The study examined the associated adverse events following SARS-CoV-2 vaccination among healthcare workers during the first dose of the vaccine in the Northern Region of Ghana.

DESIGN:

The study was a cross-sectional survey involving 463 healthcare workers.

METHOD:

The data were collected using a structured questionnaire. The data were analysed descriptively, and binary logistics was performed using SPSS version 25.

RESULTS:

The mean age was 33.4 ± 9.7 years, the majority (43.6%) being ≤30 years and males (57.2%). The self-reported prevalence of SARS-CoV-2 vaccine adverse events was 75.5%. Common systemic adverse events comprised headache (47.5%), dizziness (18.4%) and local adverse events included generalized body pains (44.0%) and abscess around the injection sites (11.2%). The study found a high prevalence of self-reported SARS-CoV-2 vaccine adverse events involving both systemic and local adverse events. Our study gives useful information that can be used for public health-targeted interventions to boost public confidence in SARS-CoV-2 vaccines.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Qualitative_research / Risk_factors_studies Limite: Adult / Humans / Male País como assunto: Africa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Qualitative_research / Risk_factors_studies Limite: Adult / Humans / Male País como assunto: Africa Idioma: En Ano de publicação: 2023 Tipo de documento: Article